Technical Analysis for FLGT - Fulgent Genetics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Historical FLGT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 4.54% | |
| Multiple of Ten Bearish | Other | 4.54% | |
| Wide Bands | Range Expansion | 4.54% | |
| Overbought Stochastic | Strength | 4.54% | |
| Bearish Engulfing | Bearish | -0.35% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakout | about 13 hours ago | |
| Rose Above 10 DMA | about 13 hours ago | |
| 10 DMA Resistance | about 18 hours ago | |
| Up 3% | about 19 hours ago | |
| Up 2% | about 19 hours ago |
Get a Trading Assistant
- Earnings date: 11/09/2020
Fulgent Genetics, Inc. Description
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancers Genetics Cardiovascular Disease Medical Genetics Medical Tests Algorithms Neurological Disorders Vascular Diseases Molecular Diagnostics Cardiovascular Diseases Urological Disorders Applied Genetics Genetic Testing Adaptive Learning Qiagen Alternatives To Animal Testing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 79.63 |
| 52 Week Low | 6.7 |
| Average Volume | 2,068,237 |
| 200-Day Moving Average | 32.70 |
| 50-Day Moving Average | 50.99 |
| 20-Day Moving Average | 61.91 |
| 10-Day Moving Average | 68.66 |
| Average True Range | 6.09 |
| ADX | 29.65 |
| +DI | 27.45 |
| -DI | 17.60 |
| Chandelier Exit (Long, 3 ATRs ) | 61.37 |
| Chandelier Exit (Short, 3 ATRs ) | 60.77 |
| Upper Bollinger Band | 80.91 |
| Lower Bollinger Band | 42.91 |
| Percent B (%b) | 0.69 |
| BandWidth | 61.38 |
| MACD Line | 6.14 |
| MACD Signal Line | 6.13 |
| MACD Histogram | 0.0098 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 74.45 | ||||
| Resistance 3 (R3) | 73.94 | 71.71 | 73.58 | ||
| Resistance 2 (R2) | 71.71 | 70.38 | 71.96 | 73.29 | |
| Resistance 1 (R1) | 70.47 | 69.56 | 71.09 | 70.98 | 73.00 |
| Pivot Point | 68.24 | 68.24 | 68.55 | 68.49 | 68.24 |
| Support 1 (S1) | 67.00 | 66.91 | 67.62 | 67.51 | 65.48 |
| Support 2 (S2) | 64.77 | 66.09 | 65.02 | 65.19 | |
| Support 3 (S3) | 63.53 | 64.77 | 64.90 | ||
| Support 4 (S4) | 64.04 |
